These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 37582536)

  • 21. When is it Safe to Edit the Human Germline?
    Baxter J
    Sci Eng Ethics; 2021 Jul; 27(4):43. PubMed ID: 34231047
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Does human genome editing reinforce or violate human dignity?
    Segers S; Mertes H
    Bioethics; 2020 Jan; 34(1):33-40. PubMed ID: 31222790
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fighting trafficking of falsified and substandard medicinal products in Russia.
    Fayzrakhmanov NF
    Int J Risk Saf Med; 2015; 27 Suppl 1():S37-40. PubMed ID: 26639702
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Why human germline genome editing is incompatible with equality in an inclusive society.
    MacKellar C
    New Bioeth; 2021 Mar; 27(1):19-29. PubMed ID: 33459206
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Balancing Innovation, 'Ordre Public' and Morality in Human Germline Editing: A Call for More Nuanced Approaches in Patent Law.
    Matthews D; Minssen T; Nordberg A
    Eur J Health Law; 2022 Apr; 29(3-5):562-588. PubMed ID: 37582537
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Making sense of heritable human genome editing: Scientific and ethical considerations.
    Greenfield A
    Prog Mol Biol Transl Sci; 2021; 182():1-28. PubMed ID: 34175039
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Human Right to Science and the Regulation of Human Germline Engineering.
    Boggio A; Knoppers BM; Almqvist J; Romano CPR
    CRISPR J; 2019 Jun; 2():134-142. PubMed ID: 31225756
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Responsible innovation in human germline gene editing: Background document to the recommendations of ESHG and ESHRE.
    De Wert G; Heindryckx B; Pennings G; Clarke A; Eichenlaub-Ritter U; van El CG; Forzano F; Goddijn M; Howard HC; Radojkovic D; Rial-Sebbag E; Dondorp W; Tarlatzis BC; Cornel MC;
    Eur J Hum Genet; 2018 Apr; 26(4):450-470. PubMed ID: 29326429
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Germ-Inating Solutions or Gene-Rating Problems: An Islamic Perspective on Human Germline Gene Editing.
    Lala I
    J Relig Health; 2020 Aug; 59(4):1855-1869. PubMed ID: 30778792
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impacts of the EU GMO regulatory framework for plant genome editing.
    Hundleby PAC; Harwood WA
    Food Energy Secur; 2019 May; 8(2):e00161. PubMed ID: 31423300
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Germ line genome editing in clinics: the approaches, objectives and global society.
    Ishii T
    Brief Funct Genomics; 2017 Jan; 16(1):46-56. PubMed ID: 26615180
    [TBL] [Abstract][Full Text] [Related]  

  • 32. What Would It Take to Enable Germline Editing in Europe for Medical Purposes?
    Slokenberga S
    Eur J Health Law; 2022 Apr; 29(3-5):521-542. PubMed ID: 37582540
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Idea of Precaution: Ethical Requirements for the Regulation of New Biotechnologies in the Environmental Field.
    Rippe KP; Willemsen A
    Front Plant Sci; 2018; 9():1868. PubMed ID: 30622545
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genome Editing for Longer Lives: The Problem of Loneliness.
    Wareham CS
    J Bioeth Inq; 2020 Jun; 17(2):309-314. PubMed ID: 32152896
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genome engineering through CRISPR/Cas9 technology in the human germline and pluripotent stem cells.
    Vassena R; Heindryckx B; Peco R; Pennings G; Raya A; Sermon K; Veiga A
    Hum Reprod Update; 2016 Jun; 22(4):411-9. PubMed ID: 26932460
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The implications of the gender-based prohibitions relating to human germline genome editing in the Human Fertilisation and Embryology Act.
    Kaur A
    Reprod Biomed Online; 2021 Feb; 42(2):457-462. PubMed ID: 33293222
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A Review of Regulations Applicable to Human Germline Cell Editing in Australia and around the World.
    de Zwart M; Floreani C
    J Law Med; 2022 Jun; 29(2):599-609. PubMed ID: 35819394
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ethical Considerations in Therapeutic Clinical Trials Involving Novel Human Germline-Editing Technology.
    Brokowski C; Adli M
    CRISPR J; 2020 Feb; 3(1):18-26. PubMed ID: 32091258
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Somatic Genome Editing with the Use of AI: Big Promises but Doubled Legal Issues.
    Kiseleva A
    Eur J Health Law; 2022 Apr; 29(3-5):381-408. PubMed ID: 37582541
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Is selecting better than modifying? An investigation of arguments against germline gene editing as compared to preimplantation genetic diagnosis.
    V Hammerstein AL; Eggel M; Biller-Andorno N
    BMC Med Ethics; 2019 Nov; 20(1):83. PubMed ID: 31752935
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.